SXC Health Solutions, Inc. (SXCI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SXC Health Solutions, Inc. (SXCI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: JakeStraw	3/4/2010 7:59:51 AM
	of 61

SXC Health solutions announces Strong fourth quarter and year end financial results finance.yahoo.com 2009 Financial Highlights ------------------------- - Revenue was $1.4 billion in 2009 compared to $862.9 million in 2008 - Gross profit was $186.6 million in 2009 compared to $115.5 million in 2008 - Adjusted EBITDA(1) was $94.7 million in 2009 compared to $42.5 million in 2008 - GAAP net income increased to $46.1 million, or $1.72 per share (fully-diluted), in 2009 compared to $15.1 million, or $0.65 per share (fully-diluted), in 2008 - Non-GAAP adjusted earnings per share(1) (diluted), which excludes the NMHC transaction-related amortization net of tax, was $1.91 in 2009 compared to $0.89 in 2008 - Cash from operations was $86.4 million in 2009 compared to $41.6 million in 2008 - Adjusted prescription claim volume(1) for the PBM segment was 11.1 million in Q4-2009 compared to 9.9 million in Q3-2009 - Gross margin per adjusted prescription for the PBM segment was $3.47 in Q4-2009 compared to $3.35 in Q4-2008 - Mail order penetration increased to 11% in Q4-2009 compared to 9.5% in Q3-2009 - Transaction processing volume for the HCIT segment was 94.6 million in Q4-2009 compared to 92.0 million in Q3-2009 2009 Corporate Highlights ------------------------- - Awarded new business with the Ohio Bureau of Workers' Compensation, the UFCW & Employers Benefit Trust, the Commonwealth of Virginia, Presbyterian Health Plan, Spectral Solutions, Prime Therapeutics LLC and PharMerica Corporation - Renewed a multi-year PBM contract with the Employer-Union Health Benefits Trust Fund of Hawaii - Entered into a strategic relationship with Allscripts Misys to enhance the E-Prescribing options available to SXC's clients - Completed a public offering of 5,175,000 common shares at a price of $41.50 per share resulting in net proceeds of approximately $203.1 million 2010 Full Year Financial Guidance SXC has set the following financial targets for 2010: - Revenue of $1.9 to $2.0 billion - Gross profit of $195 to $205 million - Adjusted EBITDA of $108 to $112 million - Fully-diluted GAAP EPS of $1.79 to $1.87 - Adjusted EPS of $1.92 to $2.00

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next